Pharmaceutical formulation of fluticasone propionate

Details Pharmaceutical formulation of fluticasone propionate Pharmaceutical formulation of fluticasone propionate

2007-05-22

2007-05-22

Padmanabhan, Sreeni (Department: 1616)

Drug, bio-affecting and body treating compositions

Effervescent or pressurized fluid containing

Organic pressurized fluid

C424S043000, C424S434000, C128S200140

Reexamination Certificate

active

10630655

ABSTRACT:
There is provided according to the invention a pharmaceutical aerosol formulation which comprises:(i) fluticasone propionate and(ii) a hydrofluoroalkane (HFA) propellant,characterised in that the fluticasone propionate is completely dissolved in the formulation. The invention also provided canisters containing the formulation and uses thereof.

REFERENCES:
patent: 4243548 (1981-01-01), Heeb et al.
patent: 5653962 (1997-08-01), Akehurst, et al.
patent: 5736124 (1998-04-01), Akehurst et al.
patent: 5914122 (1999-06-01), Otterbeck et al.
patent: 5919827 (1999-07-01), Barberich, et al.
patent: 6004537 (1999-12-01), Cavanaugh, et al.
patent: 6241969 (2001-06-01), Saidi et al.
patent: 6309623 (2001-10-01), Weers et al.
patent: 6479035 (2002-11-01), Cripps et al.
patent: 6630129 (2003-10-01), Cripps et al.
patent: B-90873/91 (1992-05-01), None
patent: 2094266 (1998-04-01), None
patent: 0 416 951 (1991-03-01), None
patent: 94 13262 (1994-06-01), None
patent: 0 553 298 (1994-11-01), None
patent: 00 30607 (2000-06-01), None
patent: 1084726 (2001-03-01), None
patent: 2 235 627 (1991-03-01), None
patent: WO 92/06675 (1992-04-01), None
patent: WO 93/11743 (1993-06-01), None
patent: WO 93/11745 (1993-06-01), None
patent: WO 94/13262 (1994-06-01), None
patent: WO 96/32151 (1996-10-01), None
patent: WO 98/24420 (1998-06-01), None
patent: WO 98/56349 (1998-12-01), None
patent: WO 99/55600 (1999-11-01), None
patent: WO 99/65464 (1999-12-01), None
patent: WO 00/06121 (2000-02-01), None
patent: WO 00/30607 (2000-06-01), None
patent: WO 00/48587 (2000-08-01), None
patent: 01/37805 (2001-05-01), None
patent: WO 01/37805 (2001-05-01), None
patent: WO 01/58508 (2001-08-01), None
Davis et al, Physico-chemical studies on aerosol solutions for drug delivery II, water-propylene glycol-ethanol system, International Journal of Pharmaceutics, 1(1978) 85-93.
Richard N. Dalby, et al., “Comparison of Output Particle Size Distributions from Pressurized Aerosols Formulated as Solutions or Suspensions”, Pharmaceutical Research, 1988, vol. 5, No. 1, pp. 36-39.
S.S. Davis, “Physico-Chemical Studies on Aerosol Solutions for Drug Delivery I. Water-Propylene Glycol Systems”, International Journal of Pharmaceutics, 1978, vol. 1, pp. 71-83.
S.S. Davis, “Physico-Chemical Studies on Aerosol Solutions for Drug Delivery II. Water-Propylene Glycol-Ethanol Systems”, International Journal of Pharmaceutics, 1978, vol. 1, pp. 85-93.
Peter Zanan, et al., “The optimal particle size for β-adrenergic aerosols in mild asthmatics”, International Journal of Pharmaceutics, 1994, vol. 107, pp. 211-217.
Peter Zanan, et al., “The optimal particle size for parasympathicolytic aerosols in mild asthmatics”, International Journal of Pharmaceutics, 1995, vol. 114, pp. 111-115.
Peter Zanan, et al., “Optimal particle size for β2agonist and anticholinergic aerosols in patients with severe airflow obstruction”, Thorax, 1996, vol. 51, pp. 977-980.

Affiliated with

Also associated with

Rating

Pharmaceutical formulation of fluticasone propionate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical formulation of fluticasone propionate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation of fluticasone propionate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3741791